William Chase - Apr 14, 2023 Form 3 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
Director
Signature
/s/ James Basta, Attorney-in-fact
Stock symbol
NTLA
Transactions as of
Apr 14, 2023
Transactions value $
$0
Form type
3
Date filed
4/18/2023, 04:49 PM
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NTLA Common Stock 6.8K Apr 14, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 - Power of Attorney